within Pharmacolibrary.Drugs.ATC.V;

model V09BA03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0011666666666666668,
    adminDuration  = 600,
    adminMass      = 740 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00011999999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V09BA03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Technetium (99mTc) pyrophosphate is a radiopharmaceutical agent used primarily in nuclear medicine imaging for the diagnosis of acute myocardial infarction and for bone imaging in certain conditions. It is administered intravenously, and its uptake in tissues is utilized in noninvasive diagnostic imaging. The agent is approved and still in use for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are typically referenced for adult patients following intravenous administration in the context of myocardial infarct imaging procedures. No detailed pharmacokinetic compartmental models with exact numeric parameters were identified in primary literature; information herein is based on general radiopharmaceutical behavior and limited manufacturer datasheets.</p><h4>References</h4><ol><li><p>Haapaniemi, T, et al., &amp; Larsson, J (1996). Hyperbaric oxygen reduces ischemia-induced skeletal muscle injury. <i>Plastic and reconstructive surgery</i> 97(3) 602–609. DOI:<a href=\"https://doi.org/10.1097/00006534-199603000-00017\">10.1097/00006534-199603000-00017</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8596792/\">https://pubmed.ncbi.nlm.nih.gov/8596792</a></p></li><li><p>Bevan, JA, et al., &amp; Barnett, BL (1980). Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 21(10) 961–966. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6252298/\">https://pubmed.ncbi.nlm.nih.gov/6252298</a></p></li><li><p>Duska, F, et al., &amp; Mazurová, Y (1985). Scintigraphic detection of experimental myocardial infarction with 99mTc-heparin in the dog. <i>Nuklearmedizin. Nuclear medicine</i> 24(3) 111–114. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4059062/\">https://pubmed.ncbi.nlm.nih.gov/4059062</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V09BA03;
